Psyence Group Announces Private Placement
TORONTO, Dec. 02, 2021 (GLOBE NEWSWIRE) — Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the…
TORONTO, Dec. 02, 2021 (GLOBE NEWSWIRE) — Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the…
MENLO PARK, Calif., Dec. 02, 2021 (GLOBE NEWSWIRE) — Talis Biomedical Corporation (Nasdaq: TLIS), a…
PRESS RELEASE December 2, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on…
Data add to the growing body of evidence supporting the efficacy and safety profile of…
TORONTO and CHICAGO, Dec. 02, 2021 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”)…
SOUTH SAN FRANCISCO, Calif., Dec. 02, 2021 (GLOBE NEWSWIRE) — Lyell Immunopharma, Inc. (Lyell), (Nasdaq:…
Conference Call and Webcast Scheduled for December 15, 2021, 4:30 pm ET NEW YORK, NY,…
Entered into $31.25 million Private Placement Agreement Completed Initial Public Offering of Common Stock and…
Designation covers UV1 in Metastatic Melanoma as sole agent or part of combination Seven-year market…
Saint-Herblain (France), December 2, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty…
Oslo, 2 December 2021, Carlos de Sousa, Chief Executive Officer and primary insider in Ultimovacs…
VANCOUVER, British Columbia, Dec. 02, 2021 (GLOBE NEWSWIRE) — Pan-Biome Pharmaceuticals, Inc., a Vancouver based…
Carson City, Nevada, Dec. 02, 2021 (GLOBE NEWSWIRE) — Pharmagreen Biotech, Inc., (OTC Pink: PHBI),…
DALLAS, Dec. 02, 2021 (GLOBE NEWSWIRE) — Rapid Therapeutic Science Laboratories (OTC: RTSL) (“Rapid Therapeutic”…
WOBURN, Mass., Dec. 02, 2021 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company…
Transaction provides Bespoke with a licensed marijuana infused production facility in Colorado. DENVER, Colorado., Dec….
Company Earns Spot on Both Lists for Second Year in a Row CAMBRIDGE, Mass., Dec….
EMERYVILLE, Calif. and MARSEILLE, France, Dec. 02, 2021 (GLOBE NEWSWIRE) — Berkeley Lights, Inc. (Nasdaq:…
WOBURN, Mass., Dec. 02, 2021 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience…
– New chief business officer to oversee Company’s corporate and business development strategy – BOSTON,…